Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.620
+0.020 (1.25%)
At close: Sep 16, 2025, 4:00 PM EDT
1.620
0.00 (0.00%)
After-hours: Sep 16, 2025, 4:10 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $87.02 million as of September 16, 2025. Its market cap has increased by 206.74% in one year.
Market Cap
87.02M
Enterprise Value
69.80M
1-Year Change
206.74%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $87.02M, a decrease of -89.83%. That is a compound annual growth rate of -30.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 85.94M | 4.45% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | 819.45M | -45.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |